GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IDT Australia Ltd (ASX:IDT) » Definitions » EBITDA Margin %

IDT Australia (ASX:IDT) EBITDA Margin % : -31.24% (As of Dec. 2024)


View and export this data going back to 1991. Start your Free Trial

What is IDT Australia EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. IDT Australia's EBITDA for the six months ended in Dec. 2024 was A$-3.18 Mil. IDT Australia's Revenue for the six months ended in Dec. 2024 was A$10.18 Mil. Therefore, IDT Australia's EBITDA margin for the quarter that ended in Dec. 2024 was -31.24%.


IDT Australia EBITDA Margin % Historical Data

The historical data trend for IDT Australia's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDT Australia EBITDA Margin % Chart

IDT Australia Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.11 11.52 -3.02 -127.38 -38.04

IDT Australia Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -228.54 -73.71 -62.48 -19.36 -31.24

Competitive Comparison of IDT Australia's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDT Australia's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IDT Australia's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where IDT Australia's EBITDA Margin % falls into.


;
;

IDT Australia EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

IDT Australia's EBITDA Margin % for the fiscal year that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=-5.031/13.226
=-38.04 %

IDT Australia's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-3.18/10.179
=-31.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDT Australia  (ASX:IDT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


IDT Australia EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of IDT Australia's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


IDT Australia Business Description

Traded in Other Exchanges
N/A
Address
45 Wadhurst Drive, Boronia, Melbourne, VIC, AUS, 3155
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.